Viewing nowLipistain Tablet 20 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 20.72mg
Tablet · Prescription medication
Bukwang Pharmaceutical Co., Ltd.

MFDS item code 201403179 · Approved 2014.07.16 · Insurance code 642203440
Improvement of hyperlipidemia; prevention of cardiovascular diseases (such as myocardial infarction and stroke)
This medication helps reduce the risk of cardiovascular diseases. It particularly reduces the risk of various heart-related diseases, including myocardial infarction, stroke, complications after vascular interventions, and angina pectoris. In patients with hyperlipidemia, it lowers cholesterol and triglyceride levels while increasing good cholesterol (HDL), thereby improving vascular health. It is safe to use in pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia to help manage lipid levels in the blood. Overall, this drug is used to protect heart and vascular health and prevent the progression of related diseases.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring greater reductions in LDL cholesterol may start at 20 mg or 40 mg once daily (only for those requiring an LDL cholesterol reduction of 45 % or more). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized based on patient characteristics, taking treatment goals and response into consideration. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, LDL cholesterol levels are recommended for use when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. Elderly patients: The efficacy and safety in patients aged 70 years and older are similar to those in the general adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose of this medicine is 10 mg once daily, and the recommended maximum dose is 20 mg per day (there are no clinical data on doses greater than 20 mg in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goals for each patient. The dose should be adjusted at intervals of 4 weeks or longer.
This drug must be discontinued immediately if any abnormal symptoms occur in the muscles. This is particularly applicable in cases of muscle pain or weakness, and if there is a significant increase in creatine kinase (CK) levels in blood tests. This drug should not be administered to patients with certain diseases or those taking specific medications. For instance, it should not be used in patients with severe liver dysfunction, women who are pregnant or breastfeeding, children under 10 years old, and patients allergic to this drug or any of its components. Patients with a history of liver disease or alcoholism, patients with reduced kidney function, patients with hypothyroidism, and the elderly should use this medication cautiously and may require consultation and testing by a physician. While taking this medication, liver function and muscle status should be regularly monitored. If there are symptoms of liver dysfunction or muscle pain, weakness, fever, or fatigue, healthcare professionals should be notified immediately. This drug may interact with other medications, so caution is needed, particularly when taken with certain antibiotics, antifungals, antivirals, immunosuppressants, and some lipid-lowering agents. Patients should inform their doctor or pharmacist about any other medications they are taking. Women who are pregnant or may become pregnant should not take this medication and should use effective contraception while on this medication. Furthermore, breastfeeding women should also avoid taking this drug. The long-term safety and efficacy of this drug in children and adolescents have not been fully studied, so it should be used cautiously in patients under 18 years of age. In cases of overdose, there is no specific antidote, and appropriate treatment should be given according to the symptoms, and the condition should be monitored through liver function and muscle-related tests. This medication should be stored out of reach of children and kept in its original container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is also recommended to store the drug at room temperature between 1°C and 30°C. Take care to avoid placing it in excessively hot or cold environments.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 20.72mg
Tablet · Prescription medication
Bukwang Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.